Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Melatonin for delirium prevention in adult ICU patients
ACTRN12616000436471Phase 3Completed
- Sponsor
- Sir Charles Gairdner Hospital
- Start
- Jul 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in delirium comparing Melatonin with Placebo (2 arms). Primary endpoint: Delirium-free assessments. Started Jul 2016; status: completed.
02
Drugs
melatonin
03
Conditions
delirium
Beyond the preview
Go deeper on ACTRN12616000436471.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12616000436471.